Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Traxion Sab De Cv Ord Shs GRPOF

Grupo Traxion SAB de CV is a Mexico-based company engaged in the transportation sector. The Company provides logistics services within eight business areas: Fright, including intermodal and multimodal services, door-to-door, national and cross-border distribution, among others; Integrated logistics, including logistics management, aerial and maritime services and custom transportation support services; Warehousing, including dedicated storage, shared warehouses, packing and value-added services, such as labeling and products assembly; Logistics systems, including software for logistics management; Passenger transportation, including transportation of personnel and students; Special services, including rental of bus and vans; Moving, including national and international moving services, and Advertising, including custom transportation services during marketing campaigns. The Company operates through a number of group companies.


PINL:GRPOF - Post by User

Post by WigWagWillyon Mar 15, 2018 7:25pm
97 Views
Post# 27724284

Here is someone that could same you!

Here is someone that could same you!

[–]CytochromeP4 4 points

 

Today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the active ingredients of its PPP001 drug (delta-9-tetrahydocanabinol 9.5% and cannabidiol 2.5%) for the treatment of complex regional pain syndrome (CRPS). The Orphan-Drug Designation was granted for the active moiety of the drug PPP001 and not the formulation.

Not sure how they can grant a designation for an unspecified moiety in a specified formula. Is the ratio granted and protected? Is the concentration of each granted and protected? 

Lets pretend it's just the percentages. If the dose is 1g then you get 95mg THC and 25mg CDB in each dose. If I create a smoke-able 0.7g dose pellet with 13.57% THC and 3.57% CBD, I've recreated the exact same dose while getting around the protection of their drug. What is the real protection behind this drug? The protection could disappear overnight depending on how the US government decides to treat cannabis in the future. If the US government decided THC and CBD will not be regulated in the supplements market I can recreate these drugs and sell them as dietary supplements cheaper than the drug bought at the pharmacy. 

<< Previous
Bullboard Posts
Next >>